FTCM
BIOTU

First Trust Capital Management’s Biotech Acquisition Company Unit BIOTU Stock Holding History

First Trust Capital Management’s Portfolio BIOTU Stock Details BIOTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-90,000
Closed -$907K – 246
2021
Q2 		$907K Hold
90,000
– – 0.14% 142
2021
Q1 		$890K Buy
+90,000
New +$926K 0.17% 130

Other funds holding BIOTU

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

First Trust Capital Management's BIOTU Position: Q3 2021 in Review

First Trust Capital Management sold out of Biotech Acquisition Company Unit (BIOTU) in Q3 2021, closing a stake of 90,000 shares — an estimated $907K sold.

First Trust Capital Management first reported a position in BIOTU in Q1 2021 and held it in 2 quarters. The position peaked at $907K in Q2 2021. 34 funds tracked by Wall St. Rank hold BIOTU as of Q3 2021.

  • First Trust Capital Management reported no remaining Biotech Acquisition Company Unit position as of Q3 2021 after selling out during the quarter.
  • First Trust Capital Management sold 90,000 Biotech Acquisition Company Unit shares in Q3 2021, an estimated $907K.
  • First Trust Capital Management first reported a position in Biotech Acquisition Company Unit in Q1 2021 and held it in 2 quarters.
  • First Trust Capital Management's Biotech Acquisition Company Unit position peaked at $907K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Biotech Acquisition Company Unit as of Q3 2021.

Based on First Trust Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.